New findings from the landmark SELECT trial reveal that semaglutides cardiovascular benefits are only partly explained by reductions in waist size, suggesting broader protective effects beyond fat loss
It can be used to treat small areas of stubborn or excess fat, (including fibrous fat), on many different areas of the body, including the abdomen, flanks, upper and lower back, love handles, buttocks, thighs, knees, arms, and double chin
Now Im two weeks later with no period in sight
For example, semaglutide 2.4 mg (Wegovy) has been shown to reduce major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease, even in the absence of diabetes